{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:23:24Z","timestamp":1790162604230,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.canep.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T22:45:56Z","timestamp":1454539556000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"special_numbering":"C","title":["The epidemic of oesophageal carcinoma: Where are we now?"],"prefix":"10.1016","volume":"41","author":[{"given":"Aaron P.","family":"Thrift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2016.01.013_bib0005","unstructured":"J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. (2014). Available from: http:\/\/globocan.iarc.fr, accessed on 16\/01\/2015."},{"key":"10.1016\/j.canep.2016.01.013_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.01.013_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2016.01.013_bib0020","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/annonc\/mds181","article-title":"The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends","volume":"23","author":"Thrift","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2016.01.013_bib0025","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/djg047","article-title":"Population attributable risks of esophageal and gastric cancers","volume":"95","author":"Engel","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2016.01.013_bib0035","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/aje\/kwr117","article-title":"Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction","volume":"174","author":"Olsen","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2016.01.013_bib0040","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2016.01.013_bib0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2016.01.013_bib0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.gastro.2013.05.004","article-title":"Impact of endoscopic surveillance on mortality from Barrett\u2019s esophagus-associated esophageal adenocarcinomas","volume":"145","author":"Corley","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2016.01.013_bib0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/gutjnl-2013-305506","article-title":"Oesophageal adenocarcinoma and prior diagnosis of Barrett\u2019s oesophagus: a population-based study","volume":"64","author":"Bhat","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/gutjnl-2014-307171","article-title":"Does a prior diagnosis of Barrett\u2019s oesophagus influence risk of dying from oesophageal adenocarcinoma","volume":"64","author":"Whiteman","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajg.2014.156","article-title":"Surveillance of Barrett\u2019s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study","volume":"109","author":"Verbeek","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0075","article-title":"Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett\u2019s oesophagus","author":"El-Serag","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gutjnl-2015-309220","article-title":"Length of Barrett\u2019s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma","volume":"65","author":"Pohl","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gutjnl-2014-308802","article-title":"Impact of surveillance for Barrett\u2019s oesophagus on tumour stage and survival of patients with neoplastic progression","volume":"65","author":"Kastelein","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.canep.2013.05.011","article-title":"Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption","volume":"37","author":"Pandeya","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2016.01.013_bib0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1055-9965.EPI-12-1347","article-title":"Squamous dysplasia-the precursor lesion for esophageal squamous cell carcinoma","volume":"22","author":"Taylor","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0100","series-title":"SEER Cancer Statistics Review, 1975\u20132011","author":"Howlader","year":"2013"},{"key":"10.1016\/j.canep.2016.01.013_bib0105","unstructured":"Surveillance Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence\u2212SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973\u20132012 varying)\u2212Linked To County Attributes\u2212Total U.S., 1969\u20132013Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission."},{"key":"10.1016\/j.canep.2016.01.013_bib0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/00365521.2011.551890","article-title":"The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992\u20132006)","volume":"46","author":"Nordenstedt","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0115","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977\u20132005","volume":"101","author":"Cook","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0120","article-title":"Sex and racial disparity in incidence of esophageal adenocarcinoma: observations and explanations","author":"Thrift","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2016.01.013_bib0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2016.01.013_bib0130","doi-asserted-by":"crossref","first-page":"e103508","DOI":"10.1371\/journal.pone.0103508","article-title":"Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett\u2019s and Esophageal Adenocarcinoma Consortium (BEACON)","volume":"9","author":"Cook","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2016.01.013_bib0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2013.72","article-title":"Age at onset of GERD symptoms predicts risk of Barrett\u2019s esophagus","volume":"108","author":"Thrift","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3164\/jcbn.40.13","article-title":"Inflammation and oxidative stress in gastroesophageal reflux disease","volume":"40","author":"Yoshida","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.canep.2016.01.013_bib0145","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/djq289","article-title":"Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium","volume":"102","author":"Cook","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2016.01.013_bib0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/aje\/kwn091","article-title":"Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus","volume":"168","author":"Pandeya","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2016.01.013_bib0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2008.12.052","article-title":"Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus","volume":"136","author":"Pandeya","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2016.01.013_bib0160","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ajg.2014.71","article-title":"The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis","volume":"109","author":"Prabhu","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0165","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","article-title":"Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2016.01.013_bib0170","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-15-0323-T","article-title":"The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma","volume":"24","author":"Hazelton","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0175","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1055-9965.EPI-11-0547","article-title":"The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model","volume":"20","author":"Kong","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ajg.2013.420","article-title":"Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands","volume":"109","author":"Kroep","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0185","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2337\/diacare.28.11.2777","article-title":"Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition","volume":"28","author":"Adams","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.canep.2016.01.013_bib0190","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00125-007-0640-1","article-title":"Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer","volume":"50","author":"Yang","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.canep.2016.01.013_bib0195","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/ije\/dys176","article-title":"Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium","volume":"41","author":"Hoyo","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.canep.2016.01.013_bib0200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29432","article-title":"General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition","volume":"137","author":"Steffen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-14-103","article-title":"Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project","volume":"14","author":"Lindkvist","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0210","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jamainternmed.2015.2405","article-title":"Prevalence of overweight and obesity in the United States, 2007\u20132012","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.canep.2016.01.013_bib0215","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s10620-008-0413-9","article-title":"The association between obesity and GERD: a review of the epidemiological evidence","volume":"53","author":"El-Serag","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canep.2016.01.013_bib0220","doi-asserted-by":"crossref","first-page":"dju252","DOI":"10.1093\/jnci\/dju252","article-title":"Obesity and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus: a Mendelian randomization study","volume":"106","author":"Thrift","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2016.01.013_bib0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bjc.2014.646","article-title":"Childhood body mass index in relation to future risk of oesophageal adenocarcinoma","volume":"112","author":"Cook","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0230","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1002\/cncr.28241","article-title":"Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men","volume":"119","author":"Levi","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0235","first-page":"85","article-title":"Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma","volume":"4","author":"Vaughan","year":"1995","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0240","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cncr.26455","article-title":"Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status","volume":"118","author":"Lahmann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2016.01.013_bib0245","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/gut.2010.233866","article-title":"Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium","volume":"60","author":"Freedman","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.canep.2016.01.013_bib0250","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/j.gastro.2011.11.019","article-title":"Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis","volume":"142","author":"Liao","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2016.01.013_bib0255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","article-title":"Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus","volume":"17","author":"Sadeghi","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0260","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow","year":"1998","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.01.013_bib0265","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2016.01.013_bib0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dote.12194","article-title":"Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis","volume":"27","author":"Nie","year":"2014","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.canep.2016.01.013_bib0275","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.3748\/wjg.v19.i36.6098","article-title":"Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis","volume":"19","author":"Xie","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0280","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/ajg.2014.351","article-title":"Risk factors for Barrett\u2019s esophagus compared between African Americans and non-Hispanic Whites","volume":"109","author":"Nguyen","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0285","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cgh.2012.10.026","article-title":"A model to determine absolute risk for esophageal adenocarcinoma","volume":"11","author":"Thrift","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2016.01.013_bib0290","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1158\/1940-6207.CAPR-12-0010","article-title":"A clinical risk prediction model for Barrett esophagus","volume":"5","author":"Thrift","year":"2012","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.canep.2016.01.013_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ajg.2012.446","article-title":"Prediction of Barrett\u2019s esophagus among men","volume":"108","author":"Rubenstein","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2016.01.013_bib0300","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.cgh.2013.12.014","article-title":"A multibiomarker risk score helps predict risk for Barrett\u2019s esophagus","volume":"12","author":"Thrift","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2016.01.013_bib0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpg.2014.11.009","article-title":"Risk factors and populations at risk: selection of patients for screening for Barrett\u2019s oesophagus","volume":"29","author":"Rubenstein","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T19:27:31Z","timestamp":1537039651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782116300042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":61,"alternative-id":["S1877782116300042"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2016.01.013","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemic of oesophageal carcinoma: Where are we now?","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}